APO Research
Talk to an analyst

APO RESEARCH · REPORT

Innovations in Biologics and Biosimilars

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Innovations in Biologics and Biosimilars Industry Growth and Trends Forecast to 2032

20 December 2025120 pages

Choose your research edition.

Industry ResearchInnovations in Biologics and Biosimilars Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Innovations in Biologics and Biosimilars Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Innovations in Biologics and Biosimilars Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Innovations in Biologics and Biosimilars Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Innovations in Biologics and Biosimilars Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

According to APO Research, the global Innovations in Biologics and Biosimilars market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Innovations in Biologics and Biosimilars is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Innovations in Biologics and Biosimilars is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Innovations in Biologics and Biosimilars is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Innovations in Biologics and Biosimilars market include Changchun High Tech, Tonghua Dongbao, Sobi, Sanofi, Johnson & Johnson, Novartis, Novo Nordisk, Merck and Roche, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Innovations in Biologics and Biosimilars market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Innovations in Biologics and Biosimilars market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Innovations in Biologics and Biosimilars market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Innovations in Biologics and Biosimilars.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Innovations in Biologics and Biosimilars market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Innovations in Biologics and Biosimilars Market by Company

Changchun High Tech

Tonghua Dongbao

Sobi

Sanofi

Johnson & Johnson

Novartis

Novo Nordisk

Merck

Roche

Eli Lilly

Pfizer

Kanghong Pharma

Biogen

Amgen

AbbVie

United Laboratory

Innovent Biologics

Gan&Lee

Celltrion

3SBIO

Innovations in Biologics and Biosimilars Segment by Type

Vaccines

Insulin

Interferon

Monoclonal Antibodies

Others

Innovations in Biologics and Biosimilars Segment by Application

Hospital

Retail Pharmacy

Other

Innovations in Biologics and Biosimilars Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Innovations in Biologics and Biosimilars market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Innovations in Biologics and Biosimilars and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Innovations in Biologics and Biosimilars.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Innovations in Biologics and Biosimilars companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Innovations in Biologics and Biosimilars Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Innovations in Biologics and Biosimilars Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Innovations in Biologics and Biosimilars Market Share by Region (2021-2026) Table 4. Global Innovations in Biologics and Biosimilars Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Innovations in Biologics and Biosimilars Market Share by Region (2027-2032) Table 6. Global Innovations in Biologics and Biosimilars Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Innovations in Biologics and Biosimilars Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Innovations in Biologics and Biosimilars Market Size Share by Type (2021-2026) Table 9. Global Innovations in Biologics and Biosimilars Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Innovations in Biologics and Biosimilars Market Size Share Forecasted by Type (2027-2032) Table 11. North America Innovations in Biologics and Biosimilars Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Innovations in Biologics and Biosimilars Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Innovations in Biologics and Biosimilars Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Innovations in Biologics and Biosimilars Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Innovations in Biologics and Biosimilars Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Innovations in Biologics and Biosimilars Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Innovations in Biologics and Biosimilars Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Innovations in Biologics and Biosimilars Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Innovations in Biologics and Biosimilars Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Innovations in Biologics and Biosimilars Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Innovations in Biologics and Biosimilars Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Innovations in Biologics and Biosimilars Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Innovations in Biologics and Biosimilars Market Size Share by Application (2021-2026) Table 24. Global Innovations in Biologics and Biosimilars Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Innovations in Biologics and Biosimilars Market Size Share Forecasted by Application (2027-2032) Table 26. North America Innovations in Biologics and Biosimilars Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Innovations in Biologics and Biosimilars Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Innovations in Biologics and Biosimilars Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Innovations in Biologics and Biosimilars Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Innovations in Biologics and Biosimilars Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Innovations in Biologics and Biosimilars Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Innovations in Biologics and Biosimilars Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Innovations in Biologics and Biosimilars Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Innovations in Biologics and Biosimilars Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Innovations in Biologics and Biosimilars Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Innovations in Biologics and Biosimilars Industry Trends Table 37. Innovations in Biologics and Biosimilars Industry Drivers Table 38. Innovations in Biologics and Biosimilars Industry Opportunities and Challenges Table 39. Innovations in Biologics and Biosimilars Industry Restraints Table 40. Global Innovations in Biologics and Biosimilars Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Innovations in Biologics and Biosimilars Revenue Market Share by Company (2021-2026) Table 42. Global Innovations in Biologics and Biosimilars Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Innovations in Biologics and Biosimilars Key Company Headquarters & Area Served Table 44. Global Innovations in Biologics and Biosimilars Company, Product Type & Application Table 45. Global Innovations in Biologics and Biosimilars Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Innovations in Biologics and Biosimilars by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Changchun High Tech Company Information Table 49. Changchun High Tech Business Overview Table 50. Changchun High Tech Innovations in Biologics and Biosimilars Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Changchun High Tech Innovations in Biologics and Biosimilars Product Portfolio Table 52. Changchun High Tech Recent Development Table 53. Tonghua Dongbao Company Information Table 54. Tonghua Dongbao Business Overview Table 55. Tonghua Dongbao Innovations in Biologics and Biosimilars Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Tonghua Dongbao Innovations in Biologics and Biosimilars Product Portfolio Table 57. Tonghua Dongbao Recent Development Table 58. Sobi Company Information Table 59. Sobi Business Overview Table 60. Sobi Innovations in Biologics and Biosimilars Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Sobi Innovations in Biologics and Biosimilars Product Portfolio Table 62. Sobi Recent Development Table 63. Sanofi Company Information Table 64. Sanofi Business Overview Table 65. Sanofi Innovations in Biologics and Biosimilars Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Sanofi Innovations in Biologics and Biosimilars Product Portfolio Table 67. Sanofi Recent Development Table 68. Johnson & Johnson Company Information Table 69. Johnson & Johnson Business Overview Table 70. Johnson & Johnson Innovations in Biologics and Biosimilars Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Johnson & Johnson Innovations in Biologics and Biosimilars Product Portfolio Table 72. Johnson & Johnson Recent Development Table 73. Novartis Company Information Table 74. Novartis Business Overview Table 75. Novartis Innovations in Biologics and Biosimilars Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Novartis Innovations in Biologics and Biosimilars Product Portfolio Table 77. Novartis Recent Development Table 78. Novo Nordisk Company Information Table 79. Novo Nordisk Business Overview Table 80. Novo Nordisk Innovations in Biologics and Biosimilars Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Novo Nordisk Innovations in Biologics and Biosimilars Product Portfolio Table 82. Novo Nordisk Recent Development Table 83. Merck Company Information Table 84. Merck Business Overview Table 85. Merck Innovations in Biologics and Biosimilars Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Merck Innovations in Biologics and Biosimilars Product Portfolio Table 87. Merck Recent Development Table 88. Roche Company Information Table 89. Roche Business Overview Table 90. Roche Innovations in Biologics and Biosimilars Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Roche Innovations in Biologics and Biosimilars Product Portfolio Table 92. Roche Recent Development Table 93. Eli Lilly Company Information Table 94. Eli Lilly Business Overview Table 95. Eli Lilly Innovations in Biologics and Biosimilars Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Eli Lilly Innovations in Biologics and Biosimilars Product Portfolio Table 97. Eli Lilly Recent Development Table 98. Pfizer Company Information Table 99. Pfizer Business Overview Table 100. Pfizer Innovations in Biologics and Biosimilars Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Pfizer Innovations in Biologics and Biosimilars Product Portfolio Table 102. Pfizer Recent Development Table 103. Kanghong Pharma Company Information Table 104. Kanghong Pharma Business Overview Table 105. Kanghong Pharma Innovations in Biologics and Biosimilars Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Kanghong Pharma Innovations in Biologics and Biosimilars Product Portfolio Table 107. Kanghong Pharma Recent Development Table 108. Biogen Company Information Table 109. Biogen Business Overview Table 110. Biogen Innovations in Biologics and Biosimilars Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Biogen Innovations in Biologics and Biosimilars Product Portfolio Table 112. Biogen Recent Development Table 113. Amgen Company Information Table 114. Amgen Business Overview Table 115. Amgen Innovations in Biologics and Biosimilars Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Amgen Innovations in Biologics and Biosimilars Product Portfolio Table 117. Amgen Recent Development Table 118. AbbVie Company Information Table 119. AbbVie Business Overview Table 120. AbbVie Innovations in Biologics and Biosimilars Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. AbbVie Innovations in Biologics and Biosimilars Product Portfolio Table 122. AbbVie Recent Development Table 123. United Laboratory Company Information Table 124. United Laboratory Business Overview Table 125. United Laboratory Innovations in Biologics and Biosimilars Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. United Laboratory Innovations in Biologics and Biosimilars Product Portfolio Table 127. United Laboratory Recent Development Table 128. Innovent Biologics Company Information Table 129. Innovent Biologics Business Overview Table 130. Innovent Biologics Innovations in Biologics and Biosimilars Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Innovent Biologics Innovations in Biologics and Biosimilars Product Portfolio Table 132. Innovent Biologics Recent Development Table 133. Gan&Lee Company Information Table 134. Gan&Lee Business Overview Table 135. Gan&Lee Innovations in Biologics and Biosimilars Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Gan&Lee Innovations in Biologics and Biosimilars Product Portfolio Table 137. Gan&Lee Recent Development Table 138. Celltrion Company Information Table 139. Celltrion Business Overview Table 140. Celltrion Innovations in Biologics and Biosimilars Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Celltrion Innovations in Biologics and Biosimilars Product Portfolio Table 142. Celltrion Recent Development Table 143. 3SBIO Company Information Table 144. 3SBIO Business Overview Table 145. 3SBIO Innovations in Biologics and Biosimilars Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. 3SBIO Innovations in Biologics and Biosimilars Product Portfolio Table 147. 3SBIO Recent Development Table 148. North America Innovations in Biologics and Biosimilars Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. North America Innovations in Biologics and Biosimilars Market Size by Country (2021-2026) & (US$ Million) Table 150. North America Innovations in Biologics and Biosimilars Market Share by Country (2021-2026) Table 151. North America Innovations in Biologics and Biosimilars Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. North America Innovations in Biologics and Biosimilars Market Share Forecast by Country (2027-2032) Table 153. Europe Innovations in Biologics and Biosimilars Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe Innovations in Biologics and Biosimilars Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe Innovations in Biologics and Biosimilars Market Share by Country (2021-2026) Table 156. Europe Innovations in Biologics and Biosimilars Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe Innovations in Biologics and Biosimilars Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Innovations in Biologics and Biosimilars Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Innovations in Biologics and Biosimilars Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Innovations in Biologics and Biosimilars Market Share by Country (2021-2026) Table 161. Asia-Pacific Innovations in Biologics and Biosimilars Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Innovations in Biologics and Biosimilars Market Share Forecast by Country (2027-2032) Table 163. Latin America Innovations in Biologics and Biosimilars Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Latin America Innovations in Biologics and Biosimilars Market Size by Country (2021-2026) & (US$ Million) Table 165. Latin America Innovations in Biologics and Biosimilars Market Share by Country (2021-2026) Table 166. Latin America Innovations in Biologics and Biosimilars Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Latin America Innovations in Biologics and Biosimilars Market Share Forecast by Country (2027-2032) Table 168. Middle East & Africa Innovations in Biologics and Biosimilars Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East & Africa Innovations in Biologics and Biosimilars Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East & Africa Innovations in Biologics and Biosimilars Market Share by Country (2021-2026) Table 171. Middle East & Africa Innovations in Biologics and Biosimilars Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East & Africa Innovations in Biologics and Biosimilars Market Share Forecast by Country (2027-2032) Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Innovations in Biologics and Biosimilars Product Image Figure 3. Global Innovations in Biologics and Biosimilars Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Innovations in Biologics and Biosimilars Market Size (2021-2032) & (US$ Million) Figure 5. Global Innovations in Biologics and Biosimilars Market Share by Region: 2025 VS 2032 Figure 6. Global Innovations in Biologics and Biosimilars Market Share by Region (2021-2032) Figure 7. North America Innovations in Biologics and Biosimilars Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Innovations in Biologics and Biosimilars Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Innovations in Biologics and Biosimilars Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Innovations in Biologics and Biosimilars Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Innovations in Biologics and Biosimilars Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Vaccines Image Figure 13. Global Vaccines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Insulin Image Figure 15. Global Insulin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Interferon Image Figure 17. Global Interferon Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Monoclonal Antibodies Image Figure 19. Global Monoclonal Antibodies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Others Image Figure 21. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Innovations in Biologics and Biosimilars Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Innovations in Biologics and Biosimilars Market Share by Type 2025 VS 2032 Figure 24. North America Innovations in Biologics and Biosimilars Market Size Share by Type (2021-2032) Figure 25. Europe Innovations in Biologics and Biosimilars Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Innovations in Biologics and Biosimilars Market Size Share by Type (2021-2032) Figure 27. Latin America Innovations in Biologics and Biosimilars Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Innovations in Biologics and Biosimilars Market Size Share by Type (2021-2032) Figure 29. Hospital Image Figure 30. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Retail Pharmacy Image Figure 32. Global Retail Pharmacy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Other Image Figure 34. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Innovations in Biologics and Biosimilars Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Innovations in Biologics and Biosimilars Market Share by Application 2025 VS 2032 Figure 37. North America Innovations in Biologics and Biosimilars Market Size Share by Application (2021-2032) Figure 38. Europe Innovations in Biologics and Biosimilars Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Innovations in Biologics and Biosimilars Market Size Share by Application (2021-2032) Figure 40. Latin America Innovations in Biologics and Biosimilars Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Innovations in Biologics and Biosimilars Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Innovations in Biologics and Biosimilars Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Innovations in Biologics and Biosimilars Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Innovations in Biologics and Biosimilars Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Innovations in Biologics and Biosimilars Market Share by Country (2021-2032) Figure 47. Europe Innovations in Biologics and Biosimilars Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Innovations in Biologics and Biosimilars Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Innovations in Biologics and Biosimilars Market Share by Country (2021-2032) Figure 50. Asia-Pacific Innovations in Biologics and Biosimilars Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Innovations in Biologics and Biosimilars Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Innovations in Biologics and Biosimilars Market Share by Country (2021-2032) Figure 53. Latin America Innovations in Biologics and Biosimilars Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Innovations in Biologics and Biosimilars Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Innovations in Biologics and Biosimilars Market Share by Country (2021-2032) Figure 56. Middle East & Africa Innovations in Biologics and Biosimilars Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Innovations in Biologics and Biosimilars Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Innovations in Biologics and Biosimilars Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Vaccines
  • Insulin
  • Interferon
  • Monoclonal Antibodies
  • Others
Applications
  • Hospital
  • Retail Pharmacy
  • Other
Companies covered
  • Changchun High Tech
  • Tonghua Dongbao
  • Sobi
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Novo Nordisk
  • Merck
  • Roche
  • Eli Lilly
  • Pfizer
  • Kanghong Pharma
  • Biogen
  • Amgen
  • AbbVie
  • United Laboratory
  • Innovent Biologics
  • Gan&Lee
  • Celltrion
  • 3SBIO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Innovations in Biologics and Biosimilars Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Innovations in Biologics and Biosimilars Market Size by Region (2021-2032)
  5. 1.4.1 Global Innovations in Biologics and Biosimilars Market Size by Region (2021-2026)
  6. 1.4.2 Global Innovations in Biologics and Biosimilars Market Size by Region (2027-2032)
  7. 1.5 Key Regions Innovations in Biologics and Biosimilars Market Size (2021-2032)
  8. 1.5.1 North America Innovations in Biologics and Biosimilars Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Innovations in Biologics and Biosimilars Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Innovations in Biologics and Biosimilars Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Innovations in Biologics and Biosimilars Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Innovations in Biologics and Biosimilars Market Size Growth Rate (2021-2032)
2 Innovations in Biologics and Biosimilars Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Vaccines
  3. 2.1.2 Insulin
  4. 2.1.3 Interferon
  5. 2.1.4 Monoclonal Antibodies
  6. 2.1.5 Others
  7. 2.2 Global Innovations in Biologics and Biosimilars Market Size by Type
  8. 2.2.1 Global Innovations in Biologics and Biosimilars Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Innovations in Biologics and Biosimilars Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Innovations in Biologics and Biosimilars Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Innovations in Biologics and Biosimilars Market Size by Regions
  12. 2.3.1 North America Innovations in Biologics and Biosimilars Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Innovations in Biologics and Biosimilars Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Innovations in Biologics and Biosimilars Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Innovations in Biologics and Biosimilars Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Innovations in Biologics and Biosimilars Market Size Breakdown by Type (2021-2026)
3 Innovations in Biologics and Biosimilars Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Retail Pharmacy
  4. 3.1.3 Other
  5. 3.2 Global Innovations in Biologics and Biosimilars Market Size by Application
  6. 3.2.1 Global Innovations in Biologics and Biosimilars Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Innovations in Biologics and Biosimilars Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Innovations in Biologics and Biosimilars Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Innovations in Biologics and Biosimilars Market Size by Regions
  10. 3.3.1 North America Innovations in Biologics and Biosimilars Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Innovations in Biologics and Biosimilars Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Innovations in Biologics and Biosimilars Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Innovations in Biologics and Biosimilars Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Innovations in Biologics and Biosimilars Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Innovations in Biologics and Biosimilars Industry Trends
  2. 4.2 Innovations in Biologics and Biosimilars Industry Drivers
  3. 4.3 Innovations in Biologics and Biosimilars Industry Opportunities and Challenges
  4. 4.4 Innovations in Biologics and Biosimilars Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Innovations in Biologics and Biosimilars Revenue (2021-2026)
  2. 5.2 Global Innovations in Biologics and Biosimilars Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Innovations in Biologics and Biosimilars Key Company Headquarters & Area Served
  4. 5.4 Global Innovations in Biologics and Biosimilars Company, Product Type & Application
  5. 5.5 Global Innovations in Biologics and Biosimilars Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Innovations in Biologics and Biosimilars Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Innovations in Biologics and Biosimilars Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Innovations in Biologics and Biosimilars Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Changchun High Tech
  2. 6.1.1 Changchun High Tech Company Information
  3. 6.1.2 Changchun High Tech Business Overview
  4. 6.1.3 Changchun High Tech Innovations in Biologics and Biosimilars Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Changchun High Tech Innovations in Biologics and Biosimilars Product Portfolio
  6. 6.1.5 Changchun High Tech Recent Developments
  7. 6.2 Tonghua Dongbao
  8. 6.2.1 Tonghua Dongbao Company Information
  9. 6.2.2 Tonghua Dongbao Business Overview
  10. 6.2.3 Tonghua Dongbao Innovations in Biologics and Biosimilars Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Tonghua Dongbao Innovations in Biologics and Biosimilars Product Portfolio
  12. 6.2.5 Tonghua Dongbao Recent Developments
  13. 6.3 Sobi
  14. 6.3.1 Sobi Company Information
  15. 6.3.2 Sobi Business Overview
  16. 6.3.3 Sobi Innovations in Biologics and Biosimilars Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Sobi Innovations in Biologics and Biosimilars Product Portfolio
  18. 6.3.5 Sobi Recent Developments
  19. 6.4 Sanofi
  20. 6.4.1 Sanofi Company Information
  21. 6.4.2 Sanofi Business Overview
  22. 6.4.3 Sanofi Innovations in Biologics and Biosimilars Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Sanofi Innovations in Biologics and Biosimilars Product Portfolio
  24. 6.4.5 Sanofi Recent Developments
  25. 6.5 Johnson & Johnson
  26. 6.5.1 Johnson & Johnson Company Information
  27. 6.5.2 Johnson & Johnson Business Overview
  28. 6.5.3 Johnson & Johnson Innovations in Biologics and Biosimilars Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Johnson & Johnson Innovations in Biologics and Biosimilars Product Portfolio
  30. 6.5.5 Johnson & Johnson Recent Developments
  31. 6.6 Novartis
  32. 6.6.1 Novartis Company Information
  33. 6.6.2 Novartis Business Overview
  34. 6.6.3 Novartis Innovations in Biologics and Biosimilars Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Novartis Innovations in Biologics and Biosimilars Product Portfolio
  36. 6.6.5 Novartis Recent Developments
  37. 6.7 Novo Nordisk
  38. 6.7.1 Novo Nordisk Company Information
  39. 6.7.2 Novo Nordisk Business Overview
  40. 6.7.3 Novo Nordisk Innovations in Biologics and Biosimilars Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Novo Nordisk Innovations in Biologics and Biosimilars Product Portfolio
  42. 6.7.5 Novo Nordisk Recent Developments
  43. 6.8 Merck
  44. 6.8.1 Merck Company Information
  45. 6.8.2 Merck Business Overview
  46. 6.8.3 Merck Innovations in Biologics and Biosimilars Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Merck Innovations in Biologics and Biosimilars Product Portfolio
  48. 6.8.5 Merck Recent Developments
  49. 6.9 Roche
  50. 6.9.1 Roche Company Information
  51. 6.9.2 Roche Business Overview
  52. 6.9.3 Roche Innovations in Biologics and Biosimilars Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Roche Innovations in Biologics and Biosimilars Product Portfolio
  54. 6.9.5 Roche Recent Developments
  55. 6.10 Eli Lilly
  56. 6.10.1 Eli Lilly Company Information
  57. 6.10.2 Eli Lilly Business Overview
  58. 6.10.3 Eli Lilly Innovations in Biologics and Biosimilars Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Eli Lilly Innovations in Biologics and Biosimilars Product Portfolio
  60. 6.10.5 Eli Lilly Recent Developments
  61. 6.11 Pfizer
  62. 6.11.1 Pfizer Company Information
  63. 6.11.2 Pfizer Business Overview
  64. 6.11.3 Pfizer Innovations in Biologics and Biosimilars Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Pfizer Innovations in Biologics and Biosimilars Product Portfolio
  66. 6.11.5 Pfizer Recent Developments
  67. 6.12 Kanghong Pharma
  68. 6.12.1 Kanghong Pharma Company Information
  69. 6.12.2 Kanghong Pharma Business Overview
  70. 6.12.3 Kanghong Pharma Innovations in Biologics and Biosimilars Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Kanghong Pharma Innovations in Biologics and Biosimilars Product Portfolio
  72. 6.12.5 Kanghong Pharma Recent Developments
  73. 6.13 Biogen
  74. 6.13.1 Biogen Company Information
  75. 6.13.2 Biogen Business Overview
  76. 6.13.3 Biogen Innovations in Biologics and Biosimilars Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Biogen Innovations in Biologics and Biosimilars Product Portfolio
  78. 6.13.5 Biogen Recent Developments
  79. 6.14 Amgen
  80. 6.14.1 Amgen Company Information
  81. 6.14.2 Amgen Business Overview
  82. 6.14.3 Amgen Innovations in Biologics and Biosimilars Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Amgen Innovations in Biologics and Biosimilars Product Portfolio
  84. 6.14.5 Amgen Recent Developments
  85. 6.15 AbbVie
  86. 6.15.1 AbbVie Company Information
  87. 6.15.2 AbbVie Business Overview
  88. 6.15.3 AbbVie Innovations in Biologics and Biosimilars Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 AbbVie Innovations in Biologics and Biosimilars Product Portfolio
  90. 6.15.5 AbbVie Recent Developments
  91. 6.16 United Laboratory
  92. 6.16.1 United Laboratory Company Information
  93. 6.16.2 United Laboratory Business Overview
  94. 6.16.3 United Laboratory Innovations in Biologics and Biosimilars Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 United Laboratory Innovations in Biologics and Biosimilars Product Portfolio
  96. 6.16.5 United Laboratory Recent Developments
  97. 6.17 Innovent Biologics
  98. 6.17.1 Innovent Biologics Company Information
  99. 6.17.2 Innovent Biologics Business Overview
  100. 6.17.3 Innovent Biologics Innovations in Biologics and Biosimilars Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Innovent Biologics Innovations in Biologics and Biosimilars Product Portfolio
  102. 6.17.5 Innovent Biologics Recent Developments
  103. 6.18 Gan&Lee
  104. 6.18.1 Gan&Lee Company Information
  105. 6.18.2 Gan&Lee Business Overview
  106. 6.18.3 Gan&Lee Innovations in Biologics and Biosimilars Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Gan&Lee Innovations in Biologics and Biosimilars Product Portfolio
  108. 6.18.5 Gan&Lee Recent Developments
  109. 6.19 Celltrion
  110. 6.19.1 Celltrion Company Information
  111. 6.19.2 Celltrion Business Overview
  112. 6.19.3 Celltrion Innovations in Biologics and Biosimilars Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Celltrion Innovations in Biologics and Biosimilars Product Portfolio
  114. 6.19.5 Celltrion Recent Developments
  115. 6.20 3SBIO
  116. 6.20.1 3SBIO Company Information
  117. 6.20.2 3SBIO Business Overview
  118. 6.20.3 3SBIO Innovations in Biologics and Biosimilars Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 3SBIO Innovations in Biologics and Biosimilars Product Portfolio
  120. 6.20.5 3SBIO Recent Developments
7 North America
  1. 7.1 North America Innovations in Biologics and Biosimilars Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Innovations in Biologics and Biosimilars Market Size by Country (2021-2026)
  3. 7.3 North America Innovations in Biologics and Biosimilars Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Innovations in Biologics and Biosimilars Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Innovations in Biologics and Biosimilars Market Size by Country (2021-2026)
  3. 8.3 Europe Innovations in Biologics and Biosimilars Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Innovations in Biologics and Biosimilars Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Innovations in Biologics and Biosimilars Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Innovations in Biologics and Biosimilars Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Innovations in Biologics and Biosimilars Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Innovations in Biologics and Biosimilars Market Size by Country (2021-2026)
  3. 10.3 South America Innovations in Biologics and Biosimilars Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Innovations in Biologics and Biosimilars Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Innovations in Biologics and Biosimilars Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Innovations in Biologics and Biosimilars Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst